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Importance 
Bovine spongiform encephalopathy (BSE) is a fatal neurodegenerative disease, 
caused by a prion, that mainly affects cattle. Other ruminants, cats, nonhuman 
primates and humans are occasionally affected; this disease is called feline 
spongiform encephalopathy (FSE) in cats, and variant Creutzfeldt-Jakob disease 
(vCJD) in people. BSE is primarily acquired by eating prion-containing tissues from 
an infected animal. Cooking and standard disinfection procedures do not destroy this 
agent. Infected animals or people do not become ill for years; however, the disease is 
always progressive and fatal once clinical signs develop. BSE was first reported in the 
United Kingdom in the 1980s. Its origins are unknown; however, the recycling of 
ruminant tissues into ruminant feed amplified BSE prions and caused an explosive 
epidemic in the U.K. This epidemic peaked in 1992, with almost 1,000 new cases 
diagnosed each week. BSE also spread to many European countries, North America, 
parts of Asia and possibly other areas of the world. Control measures, including 
restrictions on ruminant feed, have now greatly decreased its prevalence, and cases 
have become uncommon or rare in many areas. Many countries have also passed new 
regulations to prevent BSE-containing tissues from entering human food supplies.  
As a result of increased surveillance, BSE prions that differ from the prion 
causing ‘classical’ BSE have been identified at very low levels in cattle populations. 
The leading hypothesis, at present, is that these atypical prions arise spontaneously in 
cattle. Some experiments suggest that an atypical prion might have given rise to the 
BSE epizootic when it was amplified in cattle feed. 
Etiology 
BSE is a member of the transmissible spongiform encephalopathies (TSEs), a 
group of neurodegenerative disorders caused by prions, infectious proteins that appear 
to replicate by converting a normal cellular protein into copies of the prion. The 
cellular protein, which is called PrPc, is found on the surface of neurons. Pathogenic 
isoforms of PrPc are designated PrPres (The ‘res’ refers to the proteinase K-resistant 
nature of prions, compared to normal PrPc). PrPSc or PrPTSE are other names for this 
protein. Prions that cause different diseases (e.g. BSE or scrapie) are considered to be 
different strains of PrPres.  
In addition to the ‘classical’ BSE prion, at least two atypical BSE prions can be 
found in cattle. One has higher molecular mass fragments than classical BSE and is 
called ‘H-type’ BSE or H-BSE; the other has a lower molecular mass and is called ‘L-
type’ BSE or L-BSE. The disease caused by the latter organism has also been termed 
‘bovine amyloidotic spongiform encephalopathy (BASE).’ Atypical BSE prions are 
thought to represent additional strains of BSE. Currently, the most likely hypothesis is 
that they arise spontaneously in cattle, similarly to some prion diseases in other 
species (e.g., spontaneous Creutzfeldt-Jakob disease in humans). L-BSE and H-BSE 
have been reported to change to a classical BSE phenotype on passage in some types 
of mice. This has led to the suggestion that one of these prions may have originally 
given rise to the BSE epidemic after amplification through the food chain. 
Species Affected 
BSE mainly occurs in cattle, but the host range of this prion is unusually broad 
compared to most prions. Rare clinical cases have been reported from goats; exotic 
ruminants in zoos, including nyala (Tragelaphus angasi), kudu (Tr. strepsiceros), 
gemsbok (Oryx gazella), eland (Taurotragus oryx), Arabian oryx (O. leucoryx), 
scimitar-horned oryx (O. dammah), ankole cattle and North American bison (Bison 
bison); various felids including housecats, cheetahs (Acinonyx jubatus), pumas (Felis 
concolor), ocelots (F. pardalis), tigers (Panthera tigris) and Asian golden cats 
(Catopuma temminckii); and captive lemurs, which were apparently infected in 
contaminated feed. (The feline spongiform encephalopathy factsheet contains details 
on infections in felids.) Sheep become ill after experimental inoculation, but no 
naturally acquired cases have been reported in this species. European red deer 
(Cervus elaphus elaphus) can also develop clinical signs if they are fed a high dose of 
prions; however, this species does not seem to easy to infect, as only one of 6 orally  
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inoculated red deer became infected. Mink (Mustela vison) 
and cynomolgus macaques (Macaca fascicularis) are also 
susceptible to oral inoculation. Common marmosets 
(Callithrix jacchus) and squirrel monkeys (Saimiri 
sciureus) have been infected by intracerebral inoculation; 
however, their natural susceptibility to BSE is unknown, as 
this method bypasses normal species barriers to prions. Pigs 
could be infected by simultaneous intracranial, intravenous 
and intraperitoneal routes or by intracerebral inoculation 
alone, but short-term feeding trials did not cause disease. 
One study reported that sea bream (Sparus aurata) seemed 
to be susceptible to oral inoculation. 
L-BSE can infect sheep and cynomolgus macaques by 
intracerebral inoculation, but there are currently no reports 
of their susceptibility by ingestion. However, L-BSE has 
been transmitted to lemurs by the oral route, with the 
development of neurological signs. Mice have been infected 
with L-BSE and H-BSE by intracerebral inoculation.  
Zoonotic potential  
Humans occasionally develop variant Creutzfeldt-
Jakob disease after eating prion-containing tissues from an 
infected animal. To date, all known cases have been caused 
by the classical BSE prion. Whether H-BSE and L-BSE can 
cause disease in people is still uncertain. Some studies in 
laboratory models, but not others, have suggested that 
humans may be susceptible to L-type BSE. 
Geographic Distribution 
Cases of classical BSE have been reported in indigenous 
cattle in some European countries, Canada, Israel and Japan. 
Some of these countries may have eradicated this disease, as 
it has not been reported in some time. Classical BSE was 
documented only in imported cattle in some nations, 
including the U.S., the Falkland Islands and Oman. Other 
countries, such as Iceland, Australia and New Zealand, seem 
to have remained completely free of classical BSE. The 
presence or absence of this disease cannot be determined in 
countries without adequate surveillance programs.   
Atypical BSE prions have been reported in Europe, the 
U.S., Canada, Japan and Brazil, as the result of surveillance 
programs for BSE. They are also likely to exist in other 
countries. 
Transmission 
BSE is usually transmitted when an animal or human 
ingests tissues containing the BSE prion. Young animals 
may be particularly susceptible: some studies suggest that 
most cattle become infected with BSE during the first six 
months of life. Sheep are, likewise, most susceptible to 
experimental (oral) inoculation during the first few months 
of life, especially during the first few weeks. In cattle, the 
prions are thought to replicate initially in the Peyer’s 
patches of the ileum, then are transported via the peripheral 
nerves to the central nervous system (CNS). Prions have 
been found in the brain of cattle as soon as 16-24 months 
after infection.  
The highest prion concentrations occur in the CNS 
(both the brain and spinal cord) and in the ileum. However, 
very sensitive detection methods have also found this agent 
in lymphoid tissues associated with the jejunum and colon, 
various nerve ganglia, peripheral nerves and adrenal glands, 
and in the optic nerve and retina. The accumulation of BSE 
in peripheral nerves, nerve ganglia and adrenal gland seems 
to coincide with or follow prion accumulation in the CNS. 
However, one group detected BSE in the jejunum as soon 
as 4 months after oral inoculation. There have been rare 
reports of BSE prions or infectivity in other locations, such 
as the tonsils; bone marrow; mesenteric lymph nodes; the 
esophagus, abomasum and rumen of one animal (possibly 
in nerve endings); sensory receptors (muscle spindles) of 
muscles but not myofibrils; one muscle sample (probably 
associated with the endings of the sciatic nerve); the tongue 
and nasal mucosa of cattle in the terminal stages of the 
disease; and even in concentrated saliva. These studies have 
generally used very sensitive techniques, found very small 
quantities of prions, and reported that these tissues contain 
prions only in animals with clinical signs. In cattle, BSE 
prions do not seem to occur in the spleen or lymphatic 
tissues other than those associated with the gastrointestinal 
tract. Most studies have also not detected BSE in muscles. 
While one group reported evidence of its presence in a few 
plasma samples from cattle, others have not detected these 
prions in bovine blood. Epidemiological evidence and 
transmission studies suggest that BSE is not transmitted in 
milk, semen or embryos.   
There is no evidence that BSE is transmitted 
horizontally between cattle; however, there is an 
unexplained increase in the risk of BSE among the 
offspring of infected animals. In one study, calves seemed 
to be more likely to develop BSE when the dam was in the 
later stages of infection (i.e., nearer to the onset of clinical 
signs). These observations have led to speculation that 
vertical transmission might be possible in cattle. If this 
occurs, it seems to be rare, and the route is unknown. 
In experimentally infected sheep, BSE prions are more 
widely disseminated in the body than in cattle. They are 
readily found in many lymphoid tissues including the 
spleen, lymph nodes and gut-associated lymphoid tissue 
(GALT), as well as in the CNS. Blood-borne transmission 
has been demonstrated in this species. A number of ewes 
(18%) also transmitted BSE to their lambs in an 
experimental flock. The lambs were more likely to become 
infected if the dam was in the later stages of the disease. 
Prions were not found in the placenta, except in one 
stillborn lamb, and the live lambs were thought to have 
been infected shortly after birth. One lamb born to an BSE-
negative sheep became infected; however, such horizontal 
transmission appears to be rare. In this experimental flock, 
a low transmission rate suggested that sheep would not 
maintain BSE long-term. 
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Prions in the environment are not thought to be 
significant in the epidemiology of BSE. Nevertheless, there 
have been concerns about their possible longevity in 
sources such as buried carcasses. In one study, infectivity 
was reported to persist for at least 265 days in sewage or 
phosphate buffered saline, under laboratory conditions. 
BSE prions detected by immunoblotting disappeared sooner 
than infectivity, and could not be found in sewage by 150 
days. Other prions (e.g., the agents of scrapie and chronic 
wasting disease) can also persist in the environment for 
prolonged periods, and hamster-adapted scrapie prions have 
been shown to survive in the soil for at least 3 years. Prions 
are reported to remain infectious after passage through the 
digestive systems of birds (crows) and mammals (coyotes). 
Atypical BSE 
In cattle, some studies report that the tissue distribution 
of atypical L-BSE and H-BSE seems to resemble that of 
classical BSE, with prions detected mainly in the CNS. 
(There are, however, some differences in the pattern of 
distribution within the brain.) H-BSE and L-BSE have also 
been found in peripheral nerves, nerve ganglia and sensory 
receptors (muscle spindles) in some studies, and L-BSE 
was detected in the adrenal gland. In one study, prions were 
found in the muscles of L-BSE infected cattle by 
immunostaining, and infectivity was detected in muscle 
homogenates with a highly sensitive mouse bioassay. 
Whether vertical transmission can occur is not known. One 
calf born to a cow in the late stages of infection with L-BSE 
was not infected.  
Transmission to humans including iatrogenic 
spread 
In humans, variant Creutzfeldt-Jakob disease usually 
results from eating BSE prions in contaminated animal 
tissues. Several patients were infected via blood 
transfusions from asymptomatically infected individuals, 
and highly sensitive prion detection techniques have found 
BSE prions in the blood of some symptomatic patients. 
There is also the potential for transmission by routes such 
as transplantation or the use of prion-contaminated 
equipment during surgeries. In humans, vCJD (BSE) prions 
can be found in the CNS, the retina and optic nerves, 
various nerve ganglia and lymphoid tissues. Prions in 
lymphoid tissues are particularly common in the spleen, 
tonsils, appendix and other GALT; however, they may also 
be found in other lymph nodes. Although very sensitive 
techniques have detected prions in the urine of some vCJD 
patients, there is no evidence that this disease can be 
transmitted during casual contact.  
Origins of the BSE epidemic 
The origins of BSE are not well understood. This 
disease was first reported in the 1980s, but it was probably 
present in cattle since the 1970s or earlier. The two most 
popular hypotheses are that BSE originated as a 
spontaneous PrPc mutation in cattle, or that it came from a 
mutated scrapie prion that contaminated ruminant feed. 
Other sources suggest that BSE might have originated from 
a wildlife population or a human TSE agent. Once the BSE 
agent entered cattle populations, it was amplified by 
recycling tissues from infected cattle into ruminant feed 
supplements, mainly as meat-and-bone meal (MBM). MBM 
is a rendered concentrate derived from animal offal and 
carcasses. While rendering cannot completely inactivate 
prions even under optimal conditions, the epidemic may 
have been facilitated by changes in rendering practices that 
allowed more prions to survive.  
Disinfection  
Complete decontamination of prion-contaminated 
tissues, surfaces and environments can be difficult. These 
agents are very resistant to most disinfectants, including 
formalin and alcohol. They are also resistant to heat, 
ultraviolet radiation, microwave irradiation and ionizing 
radiation, particularly when they are protected in organic 
material or preserved with aldehyde fixatives, or when the 
prion titer is high. Prions can bind tightly to some surfaces, 
including stainless steel and plastic, without losing 
infectivity. Prions bound to metal seem to be highly 
resistant to decontamination. Hamster-adapted scrapie 
prions are commonly used to assess prion disinfection 
methods; however, some studies have reported that BSE 
prions are more resistant to decontamination (e.g., to heat) 
than other prions. 
Few prion decontamination techniques have been 
published and confirmed to be effective for routine use. A 1-
2 N sodium hydroxide solution, or a sodium hypochlorite 
solution containing 2% available chlorine (20,000 ppm), has 
traditionally been recommended for equipment and 
surfaces. Surfaces should be treated for more than one hour 
at 20°C (68°F). Overnight disinfection is recommended for 
equipment. Cleaning before disinfection removes organic 
material that may protect prions. Experimentally, some 
milder treatments have also been effective against certain 
prions, under some conditions. They include a specific 
phenolic disinfectant, various alkaline and enzymatic 
detergents (although the efficacy of specific agents within 
these classes varies), hydrogen peroxide gas plasma, 
radiofrequency gas plasma, sodium dodecyl sulfate plus 
acetic acid, copper plus hydrogen peroxide, and others. 
New commercial decontaminants have been developed for 
prions, though published tests of their efficacy vary. Some 
laboratories pre-treat tissues with formic acid (98%) to 
decrease infectivity before sectioning tissue blocks.  
Physical inactivation of prions (e.g., on surgical 
instruments) can be carried out by porous load autoclaving 
at 134°C (273°F) for 18 minutes at 30 lb/in2. Some 
reviews also recommend 132°C (269°F) for 1 hour (gravity 
displacement sterilizer). Tissue films containing prions are 
more difficult to decontaminate by steam after they have 
dried, and human guidelines for surgical instruments 
recommend that, after use, they be kept moist or wet until 
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decontamination is performed. The cleaning agent used 
before autoclaving should also be chosen with care, as 
certain agents (e.g., some enzymatic treatments) can 
increase the resistance of prions to steam sterilization. 
Some types of samples cannot be decontaminated 
effectively even at the recommended temperatures. For 
example, tissue macerates containing BSE were reported 
to require wet heat sterilization at ≥ 155°C (311°F) for 20 
minutes, and resisted even these temperatures if the 
sample was dehydrated. Dry heat is less effective than 
moist heat; hamster-adapted scrapie prions can survive dry 
heat at temperatures as high as 360°C (680°F) for an hour, 
and one group even reported that infectivity survived 
incineration at 600°C (1112°F). A combination of 
chemical and physical decontamination can be more 
effective than either procedure alone, and effective 
combinations of chemical agents (e.g., NaOH) and 
autoclaving have been published. Even the harshest 
combination of chemical and physical disinfection is not 
guaranteed to destroy all prions in all types of samples. 
While the risk of transmitting vCJD on surgical instruments 
decontaminated with prion-specific techniques is thought to 
be very low, disposable equipment and instruments may be 
recommended during certain medical procedures. 
Anecdotal evidence and a recent study on scrapie 
suggest that decontaminating contaminated facilities, 
especially sites such as animal pens, can be very difficult. 
Incineration is commonly used for carcasses, but two 
studies found that composting may reduce or eliminate BSE 
and other prions in tissues, while another suggested that soil 
microorganisms might degrade prions in buried carcasses. 
In one of the two composting studies, BSE was found to be 
more resistant to decomposition than the prions that cause 
chronic wasting disease and scrapie. 
Infections in Animals 
Incubation Period 
The incubation period for classical BSE is estimated to 
be 2 to 8 years in cattle, and might be longer than a decade 
in a few instances. Published incubation periods in sheep 
fed BSE prions have ranged from approximately 1.5 years 
to more than 6 years. Other reported incubation periods in 
animals, after oral inoculation, are 4 years, 9 months in one 
European red deer, 15 months in mink and several years in 
experimentally infected macaques.  
Clinical Signs 
Cattle with classical BSE 
Bovine spongiform encephalopathy is a neurological 
disease that usually has an insidious onset in cattle. The 
clinical signs may include gait abnormalities (particularly 
hindlimb ataxia) and difficulty negotiating obstacles, low 
carriage of the head, hyperresponsiveness to stimuli, tremors 
and behavioral changes such as aggression, nervousness or 
apprehension, changes in temperament, and even frenzy. A 
combination of behavioral changes, hyperreactivity to 
stimuli, and gait abnormalities is highly suggestive of BSE, 
but some animals exhibit only one category of neurological 
signs. Behavioral signs are often noted initially, and 
reluctance to be milked is reported to be a common early sign 
in dairy cattle. Pacing, a modified gait in which the legs 
move in lateral pairs, occurred in 25% of the cattle with BSE 
in one study, and may be suggestive of this disease. Intense 
pruritus is not usually seen in cattle, but some animals may 
lick or rub persistently. Nonspecific signs include loss of 
condition, weight loss, teeth grinding (possibly due to 
visceral pain or neurological disease) and decreased milk 
production. Decreased rumination, bradycardia and altered 
heart rhythms have also been reported. The signs of BSE 
usually worsen gradually over a few weeks to several 
months, but rare cases can develop acutely and progress 
rapidly. Rapid, acute onset neurological disease seems to be 
particularly common in exotic ruminants in zoos. Once 
clinical signs appear, BSE is always progressive and fatal. 
The final stages are characterized by recumbency, coma and 
death.  
Cattle with atypical BSE 
The features of atypical BSE in cattle are still 
incompletely understood. H-BSE and L-BSE have usually 
been found in asymptomatic cattle during routine 
surveillance, in fallen stock (‘downer’ cattle) or at 
emergency slaughter. H-BSE in one 13-year-old cow was 
characterized by a change in behavior (unusual fear), while 
neurological signs were reported in a 19-year-old zebu bull 
(Bos indicus) with H-BSE at a zoo.  
Experiments (all using intracerebrally inoculated cattle) 
have reported varying clinical signs, with some researchers 
concluding that L-BSE can be distinguished clinically from 
classical BSE, and others reporting that the spectrum of 
clinical signs overlaps. One group reported that Friesian 
and Alpine brown cattle infected with an Italian isolate of 
L-BSE developed an illness primarily characterized by 
inactivity, "mental dullness" (e.g., decreased alertness), and 
muscle atrophy, which could be distinguished from 
classical BSE. The animals in this study were reported to be 
hyperresponsive to tactile facial stimuli, but not to light or 
sound. In this experiment, the same breeds inoculated with 
classical BSE prions developed behavioral changes (e.g., 
aggressiveness, bellowing), as well as postural 
abnormalities and hyperresponsiveness to stimuli. Another 
group found that, in Holstein-Friesian cattle inoculated with 
German isolates of H-BSE and L-BSE, the initial signs 
seemed to be more nonspecific and subtle in atypical BSE 
(e.g., weight loss and loss of condition), but the differences 
were not sufficient to unambiguously distinguish these 
forms from classical BSE. These cattle were 
hyperresponsive to acoustic and visual stimuli as well as 
tactile facial stimuli. Other clinical signs also appeared 
similar to classical BSE. A third experiment used Danish 
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Holstein/ Aberdeen Angus crosses inoculated with an 
Italian L-BSE strain and an H-BSE strain. Both “dull” and 
“nervous” forms of the illness were reported in this study; 
however, dullness was uncommon, and many cattle became 
hyperreactive to external stimuli, including tactile and facial 
stimuli. Behavioral, sensory and motor signs were all seen. 
In this study, the cattle tended to develop dysmetria and 
have difficulty in rising, but none progressed to permanent 
recumbency (unlike animals with classical BSE that 
develop ataxia). A study that used a Japanese L-BSE isolate 
in Holstein cattle reported decreased activity, 
hyperresponsiveness to stimuli, ataxia mainly of the 
hindlegs, difficulty rising and little aggression. 
Sheep with classical BSE 
Various neurological signs have been reported in 
experimentally infected sheep. In one study, Cheviot sheep 
mainly developed ataxia with minimal pruritus, and died in 
a few days to a week. In indigenous French breeds, clinical 
signs included ataxia and intense pruritus with loss of 
fleece. These animals deteriorated slowly and died in 
approximately 3 months. A third study mainly used Suffolk 
and Romney sheep, but also included a few individuals of 
other breeds, and reported that the clinical signs were 
similar in all animals. Pruritus was detected in all clinically 
affected sheep (however, it should be noted that this sign 
was also reported in 29% of the sheep that did not have 
evidence of BSE at slaughter). Other signs in some animals 
included behavioral changes, teeth grinding, movement 
abnormalities including tremor and ataxia, 
hyperresponsiveness to auditory stimuli or decreased 
menace response in a few animals, and weight loss or loss 
of body condition. Altered behavior combined with ataxia 
and pruritus were detected in 40% of these sheep.  
Goats with classical BSE 
The few BSE cases documented in naturally infected 
goats were discovered during routine surveillance at 
slaughter. One goat was a scrapie suspect. Neurological 
signs have been reported in experimentally infected 
animals. In one study, the disease was characterized by 
ataxia and tremors, and progressed rapidly in intracerebrally 
inoculated goats; however, the signs in orally inoculated 
goats were mainly lethargy and weight loss, which 
progressed to recumbency over 3 weeks. Ataxia was not 
seen in orally inoculated goats, and neither intracerebrally 
nor orally inoculated goats had signs of pruritus. In another 
study, intracerebrally inoculated Saanen goats developed 
abnormalities in movement (e.g., ataxia, tremors, postural 
deficits and especially hypermetria) and 
hyperresponsiveness to stimuli. Over the course of the 
experiment, sniffing and nibbling of the animal handlers 
and instruments changed to aversive behavior, and these 
signs became more pronounced with time. One goat carried 
its head low when undisturbed and was inappetent. Other 
signs in some animals included pruritus, an absent menace 
response, teeth grinding and weight loss.  
Other species 
Neurological signs have also been reported in other 
species inoculated experimentally with BSE. Weight loss 
preceded behavioral signs (fear, restlessness) and other 
neurological signs (e.g., stereotypic head movements, 
abnormal flicking of the ears) in one red deer. This animal 
also developed audible mouth breathing and ptyalism. In 
mink, the clinical signs included decreased appetite, 
lethargy and neurological signs, which mainly consisted of 
hindlimb ataxia, sometimes progressing to hindleg 
paralysis. Hyperexcitability and hyperaggressiveness, 
which are common in transmissible mink encephalopathy, 
were not seen in these animals.  
Nonhuman primates developed neurological signs, and 
had gradual weight loss in the later stages of the disease. 
Some orally inoculated, subclinical cynomolgus macaques 
gained weight, compared to uninoculatd animals, at a time 
when prions were accumulating in the gastrointestinal tract. 
Post Mortem Lesions      Click to view images 
Gross lesions are not found in BSE, with the exception 
of nonspecific signs, such as emaciation or wasting. The 
histopathologic lesions are confined to the CNS. Neuronal 
vacuolation and non-inflammatory spongiform changes in 
the gray matter are characteristic of the disease in cattle. 
These lesions are usually but not always bilaterally 
symmetrical. Amyloid plaques are not typical of infections 
with the classical BSE prion or H-BSE, but are associated 
with L-BSE prions. Similar spongiform changes occur in 
experimentally infected sheep and macaques. 
Diagnostic Tests 
There is no live animal test for BSE. This disease is 
usually diagnosed by detecting prions (PrPres) in the CNS. 
Sampling of the whole brain is mainly done at the level of 
the obex; however, the brainstem can be sampled through 
the foramen magnum for some purposes (e.g., for 
surveillance with rapid tests). Immunoblotting or 
immunohistochemistry are the most specific assays. A 
number of rapid diagnostic tests based on enzyme-linked 
immunosorbent assays (ELISAs), automated 
immunoblotting (Western blotting) and lateral flow assays 
are also available. Rapid tests allow large numbers of 
samples to be screened, and are often used in surveillance 
and slaughter testing. Positive samples in rapid tests are 
traditionally confirmed with immunohistochemistry or 
immunoblotting. However, the World Organization for 
Animal Health (OIE) states that confirmation of positive 
results with a second BSE rapid test is acceptable under 
some circumstances (details are available in the OIE 
Manual of Diagnostic Tests and Vaccines and at 
http://www.tse-lab-net.eu/documents/tse-oie-guide.pdf). In 
autolyzed brains, BSE may also be diagnosed by finding 
characteristic prion fibrils called scrapie-associated fibrils 
(SAF) with electron microscopy; however, this test has low 
sensitivity. Histological examination of the brain can be 
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very helpful in diagnosis (although it is not generally used 
as the sole confirmatory test), but some animals in the early 
stages of infection have few or no spongiform changes.  
Most tests used for BSE diagnosis are relatively 
insensitive and cannot detect prions in the brain until 3-6 
months before the onset of clinical signs. Highly sensitive 
assays, including protein misfolding cyclic amplification 
(PMCA) and quaking-induced conversion (QuIC) or real-
time quaking-induced conversion, may be able to identify 
prions sooner. These techniques detect tiny amounts of 
prions by their ability to convert PrPc (the normal cellular 
protein) into prions in vitro. They are being investigated for 
diagnostic use, but have not yet been formally evaluated for 
surveillance programs. BSE can also be detected by 
inoculation into mice (rodent bioassays); however, an 
incubation period of several months makes this technique 
impractical for routine diagnosis. Serology is not useful, as 
antibodies are not made against the BSE agent. 
Atypical prions (H-BSE or L-BSE) can be detected 
with the same tests, including rapid tests, as classical BSE. 
The distribution patterns of H-BSE and L-BSE in the brain 
differ somewhat from that of classical BSE, as well as from 
each other; however, these prions can also be found in the 
obex. Atypical prions can be differentiated from classical 
BSE prions by their properties in tests such as 
immunoblotting. H-BSE has higher molecular mass 
fragments than classical BSE. It also reacts with a 
monoclonal antibody to an N-terminal epitope that is not 
found in classical BSE after proteinase K cleavage. L-BSE 
has a lower molecular mass than classical BSE prions. Its 
glycosylation pattern differs from classical BSE, and it has 
an unusual deposition pattern in the brain characterized by 
amyloid plaques.  
BSE in small ruminants must be distinguished from 
scrapie, a far more common prion disease in these species. 
In most cases, this can be accomplished with conventional 
prion tests. However, BSE is more difficult to distinguish 
from certain atypical (CH1641) scrapie prions. A limited 
number of assays such as PMCA, certain special types of 
immunoblots, PrPSc profiling or epitope mapping can 
differentiate the latter two agents. 
Treatment 
There is no treatment for BSE. Suspect animals are 
usually euthanized for testing. 
Control 
Disease reporting  
Veterinarians who encounter or suspect BSE should 
follow their national and/or local guidelines for disease 
reporting. This disease is reportable in most countries. In 
the U.S., state or federal veterinary authorities should be 
informed immediately. 
 
 
Prevention  
Some countries test cattle, and sometimes sheep and 
goats, at slaughter to detect cases of BSE. In most cases, 
testing in healthy cattle and/or small ruminants intended for 
human consumption is targeted at animals over a certain 
age. At one time, Japan tested all cattle, regardless of age. 
Testing requirements for high-risk animals (e.g., 
nonambulatory cattle or those with neurological signs) are 
usually more stringent. Some countries only (or mainly) test 
high risk animals. As the prevalence of BSE has decreased, 
even nations that once tested most or all cattle have scaled 
back their testing requirements.  
When an infected animal is identified, the affected herd 
is usually quarantined, and the source of the infection 
investigated. Cohorts of an infected animal (e.g., animals 
born or raised in the same herd for the first year of life) are 
often euthanized and tested, as they are likely to have been 
exposed to the same feed at the time of highest 
susceptibility. Due to the increased risk of BSE in the 
offspring of infected cattle, these animals may also be 
traced and euthanized.  
Classical BSE can be prevented by not feeding 
ruminant tissues that may contain prions to susceptible 
species. Complete avoidance is generally necessary, as 
cooking or rendering cannot completely inactivate prions. 
Many nations have now banned the use of either ruminant 
or mammalian proteins, with certain exceptions such as 
milk and blood, in livestock feed. The specific bans, and 
protein sources prohibited, vary with the country. In some 
countries, bans also apply to other animal feeds, or even to 
fertilizer. The latter measures can help prevent cross-
contamination and accidental exposure of cattle to BSE 
prions. While feed bans can interrupt transmission and 
control BSE epidemics, the number of cases may not 
decline for some time because the incubation period for this 
disease is so long. In addition, countries may place trade 
bans on the importation of live cattle and certain ruminant 
proteins from affected countries. 
If atypical BSE represents sporadic (genetic) cases, this 
form of the disease cannot be eradicated. However, feed 
bans may help prevent these prions from being amplified in 
ruminant populations.  
Negligible, controlled and uncontrolled risk 
classifications for classical BSE 
The OIE recognizes countries as of “negligible risk” or 
“controlled risk” for classical BSE, if they conduct 
surveillance and traceback programs that meet OIE 
standards, and also fulfill certain other criteria (e.g., feed 
bans, laboratory support, BSE awareness programs for 
people who work with livestock). Countries with negligible 
risk have either had no cases of classical BSE in indigenous 
animals, or any infected animals were born more than 11 
years ago, while those classified as controlled risk have had 
more recent BSE cases. Countries that do not meet the 
standards for either negligible risk or controlled risk are 
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classified as “undetermined risk.” Atypical BSE is currently 
not considered in this system. 
Morbidity and Mortality 
Although some cases of classical BSE have been 
diagnosed in cattle as young as 22 months, the peak 
incidence occurs in 4-6 year-old-animals, and this disease is 
rare in animals less than 30 months of age. Dairy cattle 
have been predominantly affected. Nearly all L-BSE and H-
BSE prions have been found in cattle older than 8 years. 
One exception was an L-BSE prion reported from a 23-
month old steer in Japan, and another was a case thought to 
be H-BSE in a 6.5 year-old animal in Switzerland. BSE is 
always fatal once the clinical signs appear.  
At one time, the estimated prevalence of classical BSE 
in various countries ranged from more than 100 cases per 
million cattle to fewer than 2 cases per million. BSE 
epidemics were reported in several European countries. The 
first outbreak occurred in the U.K., where more than 
180,000 cases have been confirmed since the 1980s. The 
U.K. epidemic peaked in 1992, with nearly 1,000 new cases 
confirmed each week, and an annual incidence of 
approximately 2-3% in affected herds. As a result of control 
measures (particularly feed bans), the incidence declined to 
approximately 5-10 new cases per week in 2004, then to 7 
to 11 cases each year between 2009 and 2011, and 0-3 cases 
per year between 2012 and 2016. The peak of the epidemic 
curve occurred later in countries where feed bans were 
established later; however, classical BSE has now become 
rare or apparently absent in many nations. Some countries 
outside Europe also had cases of classical BSE. Japan, 
which tested all healthy cattle at slaughter until 2005, and 
cattle > 21 months of after this time, found 36 cases 
between 2001 and 2009, and none since that time. Canada 
and the U.S. have focused their test programs on high risk 
cattle (e.g., those with signs that could be consistent with 
BSE), although the U.S. conducted more extensive testing 
in 2004-2006. Canada has detected approximately 20 BSE 
cases altogether, with the most recent classical BSE case 
identified in 2015, and the U.S. has reported one case of 
classical BSE in an animal imported from Canada.  
As of 2016, approximately 100 animals infected with 
L-BSE or H-BSE have been identified worldwide. The 
majority of these animals were asymptomatic, and 
identified mainly during surveillance programs for classical 
BSE. The incidence of atypical BSE appears to be much 
lower than classical BSE. Its prevalence in France and 
Germany may be as low as 1 case per 3 million adult cattle. 
Small numbers of cases were also reported from Japan, 
Brazil and North America, including three cases in the U.S.  
Only two BSE cases have been published, to date, in 
goats, and no naturally acquired cases have been seen in 
sheep, despite their susceptibility to experimental 
infection. Some cases in small ruminants might have been 
misdiagnosed as scrapie, particularly before BSE 
surveillance was extended to these species. Surveillance 
conducted in Europe suggests that the prevalence of BSE 
is currently very low in sheep, if it occurs at all. Estimates 
of the maximum proportion of sheep TSE cases that could 
be BSE range from 0.7% to 5%. Experimentally infected 
sheep that are genetically resistant to scrapie seem to have 
some resistance to BSE after intracerebral inoculation, but 
are not immune to infection or disease. However, some 
studies suggest that these sheep (e.g., the ARR/ARR 
genotype) might be completely resistant to oral 
inoculation. 
Infections in Humans 
Incubation Period 
The incubation period for vCJD is difficult to establish 
with certainty; however, the average incubation period is 
estimated to be 11 to 12 years, and some people have 
remained asymptomatic for up to 16 years before 
developing symptoms. In three cases transmitted in blood 
transfusions, the incubation period was 6 to 8.5 years. For 
comparison, some other human prion diseases have similar 
median incubation periods, but have been reported up to 40 
years after exposure.  
Clinical Signs 
The symptoms of vCJD are broadly similar to the 
sporadic (genetic) form of CJD, but usually appear in 
younger patients. The first signs are usually psychiatric 
symptoms, such as anxiety, depression, insomnia, social 
withdrawal, delusions and/or persistent painful sensory 
symptoms. In most patients, frank neurological signs such 
as gait disturbances, ataxia, incoordination, memory loss, 
slurring of speech and tremor appear a few months later; 
however, neurological signs coincide with or precede 
psychiatric symptoms in a minority. Cognitive function 
gradually deteriorates. Involuntary movements (e.g., 
chorea, dystonia, myoclonus), visual disturbances and 
dementia typically develop late in the course of disease. 
Most patients die within two years.  
All of the known clinical cases, to date, have occurred 
in people with a certain genotype (see Morbidity and 
Mortality, below). Some authors have noted that, if other 
genotypes are more resistant but not actually immune to 
vCJD, their symptoms and/or the progression of the disease 
might differ from the syndrome described so far.  
Diagnostic Tests 
A tentative diagnosis may be made before death by the 
history, clinical signs and cortical atrophy on magnetic 
resonance imaging (MRI) of the brain. The 
electroencephalogram (EEG) is usually normal, and only 
rarely develops the characteristic abnormalities seen in 
sporadic CJD (f it occurs at all, this is seen late in the 
disease.) A definitive diagnosis can be made by finding 
prions in tonsil biopsies with immunoblotting (Western 
blotting) or immunohistochemistry. In other cases, the 
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diagnosis is made by microscopic examination of brain 
tissue, usually at necropsy. Numerous amyloid plaques 
surrounded by vacuoles are found in vCJD; such plaques 
are seen in only 5-10% of cases of sporadic (genetic) CJD. 
Large amounts of prion protein can be found around the 
plaques by immunohistochemistry. Highly sensitive prion 
techniques (e.g., PMCA, QuIC) can detect BSE prions in 
the blood of some vCJD patients and are being examined as 
potential antemortem and blood screening tests. Prions have 
also been found in the urine of some patients. 
Treatment 
No treatment is available, other than supportive care. 
While various drugs have been tried, none have been 
demonstrated to be effective, to date. 
Control 
Variant Creutzfeldt-Jakob disease can usually be 
avoided by not eating tissues from BSE-infected or 
potentially BSE-infected animals. Animals with clinical 
signs consistent with BSE (e.g., neurological signs, downer 
cattle) cannot be used as human food in many countries. 
Tissues that have a high risk of transmitting BSE in cattle 
(specified risk materials or SRM) are no longer allowed to 
enter the human food chain in many countries. They 
generally include the brain, spinal cord, associated bones 
and some associated nerve ganglia; tonsils; and various 
portions of the spinal cord (e.g., currently, the distal ileum 
in the U.S., and the last 4 meters of the small intestine, the 
cecum and mesentery in the E.U.). Surveillance of animals 
at slaughter, using rapid tests, can help prevent meat from 
infected animals from reaching the human food supply. 
(While most sources do not consider meat alone to be of 
risk, it could become contaminated with prions from 
neurological or GI lymphoid tissues during processing.) 
Slaughter and processing techniques that have a high risk of 
contaminating muscle tissues with CNS (e.g., mechanically 
separated meat) have been prohibited in many countries. In 
the E.U., some slaughter regulations now apply to sheep 
and goats, as well as cattle. 
Special prion decontamination techniques, or the use of 
disposable surgical instruments, can reduce the risk of 
person-to-person transmission during surgeries. In addition 
to the risks from neurological tissues in vCJD suspects, 
there are concerns that some asymptomatic people may 
have BSE prions in tissues such as the appendix or tonsils. 
Transmission in blood cannot be completely prevented with 
the current techniques; however, many countries restrict 
blood donations from people with a significant risk of 
having been infected during the BSE epidemics. Some 
countries have also taken other measures, such as universal 
leucodepletion of blood, to reduce the risk of vCJD. Prion 
filters have been developed to reduce infectivity in plasma, 
but are still being evaluated and are not in wide use. Some 
countries import fresh frozen plasma from low-risk 
countries for patients without dietary exposure to BSE (e.g., 
patients born after 1996 in the U.K.). 
Although laboratory or abattoir-related cases have not 
been reported, veterinarians and laboratory workers should 
always take precautions when conducting necropsies on 
BSE suspects or handling tissues; BSL-3 is the 
recommended level of protection. Because prions can 
survive in the environment for years and are difficult to 
disinfect, contamination of surfaces and equipment should 
be avoided as much as possible. Disposable plastic-coated 
paper sheets can be used to protect tables and other 
surfaces. Disposable instruments and work clothing may 
also be used.  
Morbidity and Mortality 
To date, vCJD has usually been seen in young patients. 
The reason is unknown, but it is possible that children and 
adolescents are more susceptible to infection and/or have a 
more rapid progression of disease than adults. The median 
age of onset is 26 years (range 12 to 74 years); in contrast, it 
is 65 years (range 15 to 94 years) in the sporadic (genetic) 
form of Creutzfeldt-Jakob disease. Once symptoms develop, 
vCJD is always fatal. 
As of May 2016, 228 cases of vCJD have been 
reported worldwide. This includes 178 cases in the U.K., 27 
cases in France, and < 5 cases each in various European, 
North American, Asian and the Middle Eastern countries. 
With the exception of the French cases, the vast majority 
(185 people) had resided in the U.K. for more than 6 
months during the peak of the BSE epidemic, and are likely 
to have been infected there. The number of vCJD cases 
diagnosed in recent years has been falling. The incidence in 
the U.K. peaked in 2000, when 28 cases were diagnosed, 
and gradually fell to 5 cases per year in 2005. There were 2-
5 cases per year between 2006 and 2011, and only two 
additional cases were diagnosed between 2012 and 2016. 
To date, all people with confirmed clinical cases have been 
homozygous for methionine at codon 129 in the PrPC protein 
(M/M). One person who was heterozygous for 
methionine/valine at this codon (M/V) was infected in a 
blood transfusion, but did not develop vCJD symptoms, and 
died of unrelated causes after 5 years. A possible, but 
unconfirmed, clinical case occurred in a M/V individual in 
2009. It is not yet known whether people with resistant 
genotypes (V/V or M/V) are unlikely to develop vCJD, or 
simply have a longer incubation period. 
The number of people who have been infected 
asymptomatically, and the percentage of those likely to 
develop vCJD, are still unclear. Based on the pattern of 
infection in the U.K, some sources suggest that, at most, 70 
additional cases can be expected. However, some studies 
that have examined lymphoid tissues, such as the tonsils or 
appendix, suggest that from 1 in 2000 to 1 in 10,000 people 
in the U.K. may be infected subclinically. This includes a 
recent, large scale survey, which found BSE prions in 
0.05% of appendix samples archived between 2000 and 
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2012. This study found that V/V individuals seemed to be 
overrepresented among those with BSE prions, and the M/V 
genotype was also seen. Whether these people will ever 
develop vCJD is not known. 
Internet Resources 
Canadian Food Inspection Agency 
http://www.inspection.gc.ca/animals/terrestrial-
animals/diseases/reportable/bse/eng/1323991831668/1
323991912972 
Centers for Disease Control and Prevention 
http://www.cdc.gov/prions/bse/index.html 
European Commission. TSE/BSE 
http://ec.europa.eu/food/food/biosafety/tse_bse/index_e
n.htm  
The Merck Veterinary Manual 
http://www.merckvetmanual.com/mvm/index.html  
The National Creutzfeldt-Jakob Disease Surveillance Unit, 
United Kingdom. 
www.cjd.ed.ac.uk  
United Kingdom. Department for Environment Food and 
Rural Affairs. Bovine Spongiform Encephalopathy 
https://www.gov.uk/guidance/bse 
United States Department of Agriculture (USDA), Animal 
and Plant Health Inspection Service. Bovine 
Spongiform Encephalopathy  
http://www.usda.gov/wps/portal/usda/usdahome?navty
pe=SU&navid=BSE 
United States Food and Drug Administration. Bovine 
Spongiform Encephalopathy 
http://www.fda.gov/animalveterinary/guidancecomplia
nceenforcement/complianceenforcement/bovinespongif
ormencephalopathy/default.htm  
World Health Organization. Bovine Spongiform 
Encephalopathy 
http://www.oie.int/animal-health-in-the-world/official-
disease-status/bse/list-of-bse-risk-status/  
World Organization for Animal Health (OIE) 
http://www.oie.int  
OIE Manual of Diagnostic Tests and Vaccines for 
Terrestrial Animals  
http://www.oie.int/international-standard-
setting/terrestrial-code/access-online/   
OIE Terrestrial Animal Health Code 
http://www.oie.int/international-standard-
setting/terrestrial-manual/access-online/  
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